Nexalin Technology Inc [NASDAQ: NXL] traded at a high on Thursday, posting a 79.49 gain after which it closed the day’ session at $1.40. The company report on March 28, 2024 at 8:30 AM that Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego.
Collaborative Study involving the VA and UCSD achieved statistically significant decrease in PCS and PTSD symptoms versus control group.
The data supports the Company’s strategy to offer military and civilian physicians a new tool to effectively treat mTBI without the use of medication, and without side effects or adverse events.
The results of the trading session contributed to over 11501879 shares changing hands. Over the past one week, the price volatility of Nexalin Technology Inc stands at 44.02% while the volatility over the past one month is 29.71%.
The market cap for NXL stock reached $10.42 million, with 7.44 million shares outstanding and 5.87 million shares in the current float. Compared to the average trading volume of 331.82K shares, NXL reached a trading volume of 11501879 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Nexalin Technology Inc [NXL]?
The Average True Range (ATR) for Nexalin Technology Inc is set at 0.16, with the Price to Sales ratio for NXL stock in the period of the last 12 months amounting to 94.69. The Price to Book ratio for the last quarter was 3.25, with the Price to Cash per share for the same quarter was set at 0.40.
How has NXL stock performed recently?
Nexalin Technology Inc [NXL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 213.90. With this latest performance, NXL shares gained by 348.00% in over the last four-week period, additionally plugging by 219.93% over the last 6 months – not to mention a rise of 34.62% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NXL stock in for the last two-week period is set at 87.62, with the RSI for the last a single of trading hit 91.80, and the three-weeks RSI is set at 83.83 for Nexalin Technology Inc [NXL]. The present Moving Average for the last 50 days of trading for this stock 0.4141, while it was recorded at 0.7568 for the last single week of trading, and 0.5013 for the last 200 days.
Nexalin Technology Inc [NXL]: Deeper insight into the fundamentals
Nexalin Technology Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.70 and a Current Ratio set at 8.07.
Insider trade positions for Nexalin Technology Inc [NXL]
The top three institutional holders of NXL stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in NXL stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in NXL stock with ownership which is approximately 5.8325%.
